On October 24, 2022 PhaseBio Pharmaceuticals, Inc. filed for chapter 11 protection in the District of Delaware (Case No. 22-10995). The Debtor reports assets of $10M-$50M and liabilities of $10M-$50M. The Petition states funds will be available to Unsecured Creditors.
Daniel J. DeFranceschi
Richards, Layton & Finger